202403 – Moneyspot Investment Fund Report
DOWNLOAD OUR RESEARCH REPORT
Please add your details
Thank you for lodging your complaint.
You will receive an automated email confirming receipt. If you do not
receive an email from us please contact us by telephone.
We will then acknowledge your complaint, generally within one (1)
business day, and give you the details of how you can contact us
regarding your complaint.
The person responsible for dealing with your complaint will
commence their investigation and may require further details from
you. Upon completion of their investigation, we will contact you and
may, depending upon the circumstances, provide you with our
response.
Please add your details
Please add your details
Continue to Application
Dear Investors
The Online Application for units in the MoneySpot Investment Fund was updated on 1 February 2023.
The OLIVIA123 Online Application is a secure, cloud-based application process including improved security for your personal information and enhanced functionality.
Applicants are required to initially register with OLIVIA123 by providing their name, email address and mobile phone number which will be used for multi-factor authentication and ongoing management of their applications and redemptions.
Existing Investors
Existing Investors will be required to register with OLIVIA123 only if making an application for additional units.
Once registration is complete, applications for existing investors continue to be made through an abridged process.
If your details have changed, we ask that you take the opportunity to update them. In most cases, identification will not need to be re-verified but if needed, the online process is seamless and straightforward.
Specimen Signature
We take this opportunity to advise that the OLIVIA123 online application includes capturing a specimen signature of account operators. This will greatly assist with the secure administration of your investments in the future.
MSI Funds Management Limited
Responsible Entity for the MoneySpot Investment Fund
2 November 2023